m.strand_rph
TL3 Pharmacist · Malmö, SE
Pharmacist with a formulation background. Excipients, buffers, pH, and why your vial went cloudy.
Joined 15 October 2024 · last posted 3d · groups: pharmacists, analytical-chemists
131Posts here
3Topics
3Solutions
933Likes received
583Likes given
29Badges
118Days visited
3kPosts read
Stated areas
Recent activity
Full stream-
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #111 · Analytics › Impurities & related substances · 25 Jul 2026 · 12 likes Incomplete deprotection: mass higher by the protecting group mass. Usually markedly later eluting. A synthesis artifact from incomplete removal of protecting groups.
-
Muscle cramps: the ordinary causes before the exotic ones — a second dataset Replied, post #71 · Practice › Side effects · 24 Jul 2026 · 3 likes Muscle cramps is a good example of a question where the honest answer is boring and the interesting answers are unsupported. I would go with boring.
-
What to bring: records that a clinician can actually use Replied, post #15 · Clinical › Prescriber conversations · 24 Jul 2026 · 13 likes A question phrased as "what would you want to see before considering X" is answerable and is not a request for X.
-
Revisiting: The report format the maintainers ask for, and why each field is there Replied, post #107 · Sourcing › Vendor reports · 23 Jul 2026 · 24 likes Reports of ordinary results are more valuable than reports of remarkable ones, precisely because only the remarkable ones get posted elsewhere.
-
Asking a follow-up: new topic or new reply? Replied, post #66 · Start Here › How to Ask · 22 Jul 2026 · 19 likes Coming back to post #64, because the follow-up matters more than the original answer. I would call the community position on asking a follow-up likely rather than…
-
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #110 · Analytics › Home & field testing · 21 Jul 2026 · 4 likes Quietly grateful for the plain phrasing. Not every thread gets that.
-
Reconstituting a multi-strength kit without mixing yourself up — what changed since Replied, post #44 · Practice › Reconstitution · 21 Jul 2026 · 6 likes Reconstituting a multi-strength kit came up in a thread eighteen months ago and was answered well. I cannot find it, which is itself the problem, so here is the…
-
Here for the analytics and not much else Replied, post #69 · Lounge › Introductions · 21 Jul 2026 · 7 likes Following up: if you introduce yourself and someone asks a follow-up question, you can reply here or in a direct message depending on what feels right.
-
Follow-up: How compounding permissions changed when supply normalised Replied, post #35 · Sourcing › Regulatory · 18 Jul 2026 · 14 likes Thank you for the correction. I would rather find out here than later.
-
Batch numbers that do not match the vial label Replied, post #44 · Sourcing › Red flags · 16 Jul 2026 · 0 likes Keep the two claims separate. "The result on this lot did not match the certificate" is a report that can be checked. "This supplier is dishonest" is an allegation…
-
Journal club: indirect comparison between two programmes, defended and attacked Replied, post #113 · Evidence › Journal club · 10 Jul 2026 · 0 likes Sessions on negative or null results are consistently the most instructive and the hardest to get anyone to attend.
-
Request: a per-category review queue Replied, post #81 · Meta › Feature requests · 5 Jul 2026 · 0 likes Everything in post #79 holds. The case it does not cover is the one I have. An honest declaration on per-category review queue: I have a prior here and it is strong…
Maintains 3 documents
- Tirzepatide — referenceReview due 10 Jan 2027
- UV and diode-array detectionReview due 7 Oct 2026
- Forced degradation and stability-indicating methodsReview due 24 Mar 2027